Reports
Sale
Australia and New Zealand Endotoxin Testing Market Size: By Product & Services: Endotoxin Detection Kits & Reagents, Instruments, Systems, and Software, Endotoxin Testing Services, Others; By Test Type; By Distribution Channel; By Method; By Mode of Purchase; By Applications; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Australia and New Zealand Endotoxin Testing Market Outlook
The Australia and New Zealand endotoxin testing market size is expected to grow at a CAGR of 9.5% during the forecast period of 2024-2032, driven by increased emphasis on ensuring patient safety along with new product launches to provide enhanced results.
Australia and New Zealand Endotoxin Testing Market Overview
Endotoxin testing is a vital quality control measure used in pharmaceutical, medical device manufacturing and biotechnology domain. Endotoxins are cell wall components of certain bacteria, primarily Gram-negative bacteria such as Escherichia coli (E. coli). If present in products intended for medicinal use, the bacteria can pose serious health issues. As a result, endotoxin testing is widely used by regulatory authorities and is used to quantify and detect the presence of endotoxins in substances.
Australia and New Zealand endotoxin testing market demand is driven by increased emphasis on patient security and preventing any adverse reaction associated with injections, implantations, drugs, or biologics. With increasing biopharmaceutical production to treat rising incidence of chronic diseases, the market for endotoxin testing is poised to witness growth in the future. In addition, the advances in endotoxin testing including the advent of automated systems and more sensitive assays, have improved the efficiency and precision of the testing process significantly. This has led to widespread adoption of endotoxin testing in various industries.
New Product Launches to Boost the Australia and New Zealand Endotoxin Testing Market Growth
In August 2023, Lonza launched the Nebula® Absorbance Reader, an absorbance microplate reader to streamline pyrogen and endotoxin testing. Absorbance-based Limulus amebocyte lysate (LAL) and Tachypleus amebocyte lysate (TAL) assays have been traditionally used in pharmaceutical quality control labs. The new absorbance reader launched delivers better functionality and high performance with its compact design and monochromator-based wavelength selection to analyze precise measurements of endotoxin levels. Furthermore, the device is also enabled with WinKQCL® Endotoxin Detection and Analysis Software (v6.4), indicating the growing prevalence for digital options owing to their prompt, accurate and cost-effective results.
Increasing Advancements to Improve Existing Solutions
With an advanced understanding of biotechnological needs and rising technical innovations, prominent companies have been working to enhance their existing products based on user feedback. Such initiatives are predicted to boost the Australia and New Zealand endotoxin testing market share. In August 2023, Charles River added animal free endotoxin testing to their Endosafe solution. The company introduced Endosafe Trillium, a recombinant cascade reagent (rCR) assay developed to offer sustainable progress. The new platform stimulates the natural LAL enzymatic cascade to analyze and quantify natural environmental endotoxins along with endotoxin standards (RSE & CSE).
Rising Prevalence for Digital Solutions
In November 2023, Merck introduced ChemisTwin™, a digital reference materials platform, designed to streamline data processing for scientists to ensure quality and safety of drugs from early-stage research to development. Equipped with algorithm-based technology, the device analyses sample purity, identifies compounds, and detects degradation for over 1,500 reference materials. This platform also enables research and development professionals to boost sampling rates and detect inconsistencies at an early stage. This helps in ensuring drug safety. Australia and New Zealand endotoxin testing market size is predicted to grow multiple folds as the region continues to invest in improving the healthcare infrastructure and integrate the ongoing digital advancements to offer better outcomes.
Australia and New Zealand Endotoxin Testing Market Segmentation
Market Breakup by Product and Services
- Endotoxin Detection Kits and Reagents
- Instruments, Systems, and Software
- Endotoxin Testing Services
- Consumables and Accessories
Market Breakup by Test Type
- Limulus Amoebocyte Lysate (LAL) Test
- Monocyte Activation Test (MAT)
- Rabbit Pyrogen Test and Recombinant C (RFC) Assay
Market Breakup by Distribution Channel
- Pharmacies
- Online Channel
- Hypermarkets
Market Breakup by Method
- Gel Clot Endotoxin Test
- Chromogenic Endotoxin Test
- Turbidimetric Endotoxin Test
Market Breakup by Mode of Purchase
- Large Group
- Mid and Small Group
- Individual
Market Breakup by Applications
- Pharmaceutical Manufacturing
- Medical Device Manufacturing
- Raw Materials Production
- Packaging Manufacture
Market Breakup by End User
- Pharmaceutical Companies
- Biotechnology Companies
- Medical Device Companies
- Contract Research Organization (CRO)
- Contract Manufacturing Organization (CMO)
- Academic Research Institute and Others
Market Breakup by Country
- Australia
- New Zealand
Australia and New Zealand Endotoxin Testing Market Regional Analysis
Australia with a stringent regulatory framework such as Therapeutic Goods Administration (TGA) is predicted to lead the Australia and New Zealand endotoxin testing market share. The healthcare and pharmaceutical sector is witnessing significant expansion in the region, owing to rising investments and heightened focus on preventing infections and ensuring patient safety. New Zealand is also emerging as a significant market with a surge in research and development activities and continuous infrastructural developments in laboratories. Increasing partnerships between prominent companies and emerging start-ups are expected to boost the region’s market value in the forecast period.
Australia and New Zealand Endotoxin Testing Market: Competitor Landscape
In October 2023, Charles River Laboratories acquired BRASS Pte Ltd, a Singapore-based company, to expand their microbial detection and identification portfolio. BRASS specialises in endotoxin testing along with other tests such as bacterial and fungal identification of environmental isolates, microbial quality control analysis and sterilization validation. With this acquisition, Charles River Laboratories can offer improved and effective services and solidify their presence across the Oceania region.
The key features of the Australia and New Zealand endotoxin testing market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Viatris Inc.
- Eurofins Scientific
- Thermo Fisher Scientific
- Pall Corporation.
- Lonza Group AG
- Charles River Laboratories
- Merck KGaASteris Inc.
- Société Générale de Surveillance SA
- Sartorius AG
- GenScript
- Accugen Labs
- Sigma-Aldrich
- Nelson Laboratories and Biosynthesis
- Pacific BioLabs
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product & Services |
|
| Breakup by Test Type |
|
| Breakup by Distribution Channel |
|
| Breakup by Method |
|
| Breakup by Mode of Purchase |
|
| Breakup by Applications |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Australia and New Zealand Endotoxin Testing Market Overview
3.1 Australia and New Zealand Endotoxin Testing Market Historical Value (2017-2023)
3.2 Australia and New Zealand Endotoxin Testing Market Forecast Value (2024-2032)
4 Australia and New Zealand Endotoxin Testing Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter’s Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Australia and New Zealand Endotoxin Testing Market Segmentation
5.1 Australia and New Zealand Endotoxin Testing Market by Product & Services
5.1.1 Market Overview
5.1.2 Endotoxin Detection Kits & Reagents
5.1.3 Instruments, Systems, and Software
5.1.4 Endotoxin Testing Services
5.1.5 Consumables & Accessories
5.2 Australia and New Zealand Endotoxin Testing Market by Test Type
5.2.1 Market Overview
5.2.2 Limulus Amoebocyte Lysate (LAL) Test
5.2.3 Monocyte Activation Test (MAT)
5.2.4 Rabbit Pyrogen Test and Recombinant C (RFC) Assay
5.3 Australia and New Zealand Endotoxin Testing Market by Distribution Channel
5.3.1 Market Overview
5.3.2 Pharmacies
5.3.3 Online Channel
5.3.4 Hypermarkets
5.4 Australia and New Zealand Endotoxin Testing Market by Method
5.4.1 Market Overview
5.4.2 Gel Clot Endotoxin Test
5.4.3 Chromogenic Endotoxin Test
5.4.4 Turbidimetric Endotoxin Test
5.5 Australia and New Zealand Endotoxin Testing Market by Mode of Purchase
5.5.1 Market Overview
5.5.2 Large Group
5.5.3 Mid and Small Group
5.5.4 Individual
5.6 Australia and New Zealand Endotoxin Testing Market by Applications
5.6.1 Market Overview
5.6.2 Pharmaceutical Manufacturing
5.6.3 Medical Device Manufacturing
5.6.4 Raw Materials Production
5.6.5 Packaging Manufacture
5.7 Australia and New Zealand Endotoxin Testing Market by End User
5.7.1 Market Overview
5.7.2 Pharmaceutical Companies
5.7.3 Biotechnology Companies
5.7.4 Medical Device Companies
5.7.5 Contract Research Organization (CRO)
5.7.6 Contract Manufacturing Organization (CMO)
5.7.7 Academic Research Institute and Others
5.8 Australia and New Zealand Endotoxin Testing Market by Country
5.8.1 Market Overview
5.8.2 Australia
5.8.3 New Zealand
6 Patent Analysis
6.1 Analysis by Type of Patent
6.2 Analysis by Publication year
6.3 Analysis by Issuing Authority
6.4 Analysis by Patent Age
6.5 Analysis by CPC Analysis
6.6 Analysis by Patent Valuation
6.7 Analysis by Key Players
7 Grants Analysis
7.1 Analysis by year
7.2 Analysis by Amount Awarded
7.3 Analysis by Issuing Authority
7.4 Analysis by Grant Application
7.5 Analysis by Funding Institute
7.6 Analysis by NIH Departments
7.7 Analysis by Recipient Organization
8 Funding Analysis
8.1 Analysis by Funding Instances
8.2 Analysis by Type of Funding
8.3 Analysis by Funding Amount
8.4 Analysis by Leading Players
8.5 Analysis by Leading Investors
8.6 Analysis by Geography
9 Partnership and Collaborations Analysis
9.1 Analysis by Partnership Instances
9.2 Analysis by Type of Partnership
9.3 Analysis by Leading Players
9.4 Analysis by Geography
10 Regulatory Framework
10.1 Regulatory Overview
11 Supplier Landscape
11.1 Viatris Inc.
11.1.1 Financial Analysis
11.1.2 Product Portfolio
11.1.3 Demographic Reach and Achievements
11.1.4 Mergers and Acquisitions
11.1.5 Certifications
11.2 Eurofins Scientific
11.2.1 Financial Analysis
11.2.2 Product Portfolio
11.2.3 Demographic Reach and Achievements
11.2.4 Mergers and Acquisitions
11.2.5 Certifications
11.3 Thermo Fisher Scientific
11.3.1 Financial Analysis
11.3.2 Product Portfolio
11.3.3 Demographic Reach and Achievements
11.3.4 Mergers and Acquisitions
11.3.5 Certifications
11.4 Pall Corporation.
11.4.1 Financial Analysis
11.4.2 Financial Portfolio
11.4.3 Demographic Reach and Achievements
11.4.4 Mergers and Acquisitions
11.4.5 Certifications
11.5 Lonza Group AG
11.5.1 Financial Analysis
11.5.2 Product Portfolio
11.5.3 Demographic Reach and Achievements
11.5.4 Mergers and Acquisitions
11.5.5 Certifications
11.6 Charles River Laboratories
11.6.1 Financial Analysis
11.6.2 Product Portfolio
11.6.3 Demographic Reach and Achievements
11.6.4 Mergers and Acquisitions
11.6.5 Certifications
11.7 Merck KGaA
11.7.1 Financial Analysis
11.7.2 Product Portfolio
11.7.3 Demographic Reach and Achievements
11.7.4 Mergers and Acquisitions
11.7.5 Certifications
11.8 Steris Inc.
11.8.1 Financial Analysis
11.8.2 Product Portfolio
11.8.3 Demographic Reach and Achievements
11.8.4 Mergers and Acquisitions
11.8.5 Certifications
11.9 Société Générale de Surveillance SA
11.9.1 Financial Analysis
11.9.2 Product Portfolio
11.9.3 Demographic Reach and Achievements
11.9.4 Mergers and Acquisitions
11.9.5 Certifications
11.10 Sartorius AG
11.10.1 Financial Analysis
11.10.2 Product Portfolio
11.10.3 Demographic Reach and Achievements
11.10.4 Mergers and Acquisitions
11.10.5 Certifications
11.11 GenScript
11.11.1 Financial Analysis
11.11.2 Product Portfolio
11.11.3 Demographic Reach and Achievements
11.11.4 Mergers and Acquisitions
11.11.5 Certifications
11.12 Accugen Labs
11.12.1 Financial Analysis
11.12.2 Product Portfolio
11.12.3 Demographic Reach and Achievements
11.12.4 Mergers and Acquisitions
11.12.5 Certifications
11.13 Sigma-Aldrich
11.13.1 Financial Analysis
11.13.2 Product Portfolio
11.13.3 Demographic Reach and Achievements
11.13.4 Mergers and Acquisitions
11.13.5 Certifications
11.14 Nelson Laboratories and Biosynthesis
11.14.1 Financial Analysis
11.14.2 Product Portfolio
11.14.3 Demographic Reach and Achievements
11.14.4 Mergers and Acquisitions
11.14.5 Certifications
11.15 Pacific BioLabs
11.15.1 Financial Analysis
11.15.2 Product Portfolio
11.15.3 Demographic Reach and Achievements
11.15.4 Mergers and Acquisitions
11.15.5 Certifications
12 Australia and New Zealand Endotoxin Testing Market - Distribution Model (Additional Insight)
12.1 Overview
12.2 Potential Distributors
12.3 Key Parameters for Distribution Partner Assessment
13 Key Opinion Leaders (KOL) Insights (Additional Insight)
14 Company Competitiveness Analysis (Additional Insight)
14.1 Very Small Companies
14.2 Small Companies
14.3 Mid-Sized Companies
14.4 Large Companies
14.5 Very Large Companies
15 Payment Methods (Additional Insight)
15.1 Government Funded
15.2 Private Insurance
15.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market is anticipated to grow at a CAGR of 9.5% during the forecast period of 2024-2032, driven by growing emphasis on ensuring patient safety along with new product launches to provide enhanced results.
The market demand is driven by stringent regulatory guidelines to ensure quality control on pharmaceutical and medical device manufacturing, continuous technical developments to enhance the quality of products and rising adoption of digital platforms.
Key companies launching new products to improve the efficacy and precision of testing is a major market trend. In August 2023, Lonza launched the Nebula® Absorbance Reader, an absorbance microplate reader to streamline pyrogen and endotoxin testing. The product is based on monochromator-based wavelength selection and boasts a compact design to ensure maximum efficacy.
Based on product and service types, the market is divided into endotoxin detection kits and reagents, instruments, systems, and software, endotoxin testing services, consumables, and accessories.
Gel clot, chromogenic, and turbidimetric endotoxin tests are common methods used in endotoxin testing.
Common application areas include pharmaceutical manufacturing, medical device manufacturing, raw materials production, and packaging manufacture.
Based on test types, the market is divided into limulus amoebocyte lysate (LAL) test, monocyte activation test (MAT), rabbit pyrogen test and recombinant C (RFC) assay.
It includes large group, mid, small group and individual.
Major distribution channels include pharmacies, online channels, and hypermarkets.
Major end users include pharmaceutical companies, biotechnology companies, medical device companies, contract research organization (CRO), contract manufacturing organization (CMO) and academic research institute among others.
Based on country, it includes Australia and New Zealand.
Key players involved in the market are Viatris Inc., Eurofins Scientific, Thermo Fisher Scientific, Pall Corporation, Lonza Group AG, Charles River Laboratories, Merck KGaA, Steris Inc., Société Générale de Surveillance SA, Sartorius AG, GenScript, Accugen Labs, Sigma-Aldrich, Nelson Laboratories and Biosynthesis and Pacific BioLabs.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2199
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 3299
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 4399
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 5499
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER